NCT07077109

Brief Summary

This feasibility study will be the first study to assess the feasibility of continuous electrophysiological monitoring during maternal exercise in women with an uncomplicated pregnancy. This may help to better understand fetal condition during exercise and offer personalised exercise recommendations in the future. In future, validating the feasibility and safety of exercise could promote greater exercise engagement among pregnant women and increase fetal wellbeiing.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable pregnancy

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable pregnancy

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 22, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

October 15, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 13, 2026

Completed
Last Updated

July 28, 2025

Status Verified

July 1, 2025

Enrollment Period

3 months

First QC Date

April 22, 2025

Last Update Submit

July 23, 2025

Conditions

Keywords

Electrophysiological monitoringPregnancySportFeasibility studyMaternal exercise

Outcome Measures

Primary Outcomes (1)

  • Success rate of continuous electrophysiolgoical monitoring during maternal exercise

    Defined as the percentage of time during continuous maternal exercise with concurrent signal output of the fetal heart rate. Continous electrophysiological monitoring is feasible by a successrate of =\>80%

    15 minutes (min) before, 30 min during and 15 min after maternal exercise

Secondary Outcomes (12)

  • Maternal heartrate

    15 min before, 30 min during and 15 min after maternal exercise

  • Mean maternal heartrate

    15 min before, 30 min during and 15 min after maternal exercise

  • Fetal heart rate variability

    15 min before, 30 min during, 15 min after exercise

  • Fetal heart rate

    15 min before, 30 min during and 15 min after maternal exercise

  • Contraction frequency

    15 min before, 30 min during and 15 min after maternal exercise

  • +7 more secondary outcomes

Study Arms (1)

Electrophysiological monitoring

EXPERIMENTAL

See intervention

Device: Electrophysiological monitoring

Interventions

electrofysiological CTG monitoring with the Nemo Fetal Monitoring System (Nemo Healthcare B.V., Veldhoven, the Netherlands). The NFMS consists of a wireless and beltless electrode patch on the maternal abdomen. It monitors fetal heart rate by fetal electrocardiography, maternal heart rate by maternal electrocardiography and the electrical activity of the uterine muscle by electrohysterography.

Electrophysiological monitoring

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Minimal age of 18 years old
  • Pregnant women with an uncomplicated singleton pregnancy and a gestational age between 30+0 and 40+0 weeks and days
  • Oral and written informed consent is obtained
  • Engage in aerobic exercise during pregnancy
  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Insufficient knowledge of Dutch or English language
  • Women with a multiple pregnancy
  • Contra-indications for the Nemo Fetal Monitoring System (NFMS):
  • Fetal and/or maternal cardiac arrhythmias
  • Contraindications to abdominal placement (dermatologic diseases of the abdomen precluding preparation of the abdomen with abrasive paper)
  • Women connected to an external or implanted electrical stimulator, such as a pacemaker (because of disturbance of the electrophysiological signal)
  • Fetus with known congenital or chromosomal abnormalities
  • Mild or severe respiratory diseases (e.g. chronic obstructive pulmonary disease, restrictive lung disease and cystic fibrosis)
  • Mild or severe acquired or congenital heart disease with exercise intolerance
  • Uncontrolled or severe arrhythmia
  • +16 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Simone Goossens, PhD

    Principal Investigator

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Phebe Berben, Medical Doctor, PhD Candidate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor, PhD Candidate, Coordinating Investigator NIEM-S study

Study Record Dates

First Submitted

April 22, 2025

First Posted

July 22, 2025

Study Start

October 15, 2025

Primary Completion

December 31, 2025

Study Completion

March 13, 2026

Last Updated

July 28, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication